The OPTIMA-5 Trail

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

August 14, 2022

Study Completion Date

September 14, 2022

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Recombinant Staphylokinase

Intravenous injection of r-SAK is administered within 10 minutes after diagnosis of acute ST-segment elevation myocardial infarction

DRUG

normal saline

Intravenous injection of placebo(normal saline ) is administered within 10 minutes after diagnosis of acute ST-segment elevation myocardial infarction

Trial Locations (9)

210029

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Unknown

Changzhou Second People's Hospital, Changzhou

The second Affiliated Hospital of Dalian Medical University, Dalian

The Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou

Huai 'an Second People's Hospital affiliated to Nanjing Medical University, Huai'an

Lianyungang First People's Hospital, Lianyungang

Renji Hospital affiliated to Shanghai Jiaotong University, Shanghai

Taizhou People's Hospital, Taizhou

Affiliated Hospital of Jiangnan University, Wuxi

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT05023681 - The OPTIMA-5 Trail | Biotech Hunter | Biotech Hunter